| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10122-550-28 | 10122-550 | HUMAN PRESCRIPTION DRUG | Mycapssa | Octreotide | CAPSULE, DELAYED RELEASE | ORAL | 20200706 | N/A | NDA | NDA208232 | Chiesi USA, Inc. | OCTREOTIDE | 20 mg/1 | 4 BLISTER PACK in 1 DOSE PACK (10122-550-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
| 69880-120-28 | 69880-120 | HUMAN PRESCRIPTION DRUG | Mycapssa | Octreotide | CAPSULE, DELAYED RELEASE | ORAL | 20200706 | N/A | NDA | NDA208232 | Amryt Pharmaceuticals Designated Activity Company | OCTREOTIDE | 20 mg/1 | 4 BLISTER PACK in 1 DOSE PACK (69880-120-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |